Cargando…

Homeopathy for allergic rhinitis: protocol for a systematic review

BACKGROUND: Allergic rhinitis is a global health problem that is often treated with homeopathy. The objective of this review will be to evaluate the effectiveness of homeopathic treatment of allergic rhinitis. METHODS/DESIGN: The authors will conduct a systematic review. We will search Medline, CENT...

Descripción completa

Detalles Bibliográficos
Autores principales: Banerjee, Kushal, Costelloe, Ceire, Mathie, Robert T, Howick, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057901/
https://www.ncbi.nlm.nih.gov/pubmed/24913155
http://dx.doi.org/10.1186/2046-4053-3-59
_version_ 1782321042019057664
author Banerjee, Kushal
Costelloe, Ceire
Mathie, Robert T
Howick, Jeremy
author_facet Banerjee, Kushal
Costelloe, Ceire
Mathie, Robert T
Howick, Jeremy
author_sort Banerjee, Kushal
collection PubMed
description BACKGROUND: Allergic rhinitis is a global health problem that is often treated with homeopathy. The objective of this review will be to evaluate the effectiveness of homeopathic treatment of allergic rhinitis. METHODS/DESIGN: The authors will conduct a systematic review. We will search Medline, CENTRAL, CINAHL, EMBASE, AMED, CAM-Quest, Google Scholar and reference lists of identified studies up to December 2013. The review will include randomized controlled trials that evaluate homeopathic treatment of allergic rhinitis. Studies with participants of all ages, with acute or chronic comorbidities will be included. Patients with immunodeficiency will not be included. The diagnosis will be based on the published guidelines of diagnosis and classification. Studies of all homeopathy modalities (clinical, complex and classical homeopathy, and isopathy) will be included. We will include trials with both active controls (conventional therapy, standard care) and placebo controls. The primary outcomes are: an improvement of global symptoms recorded in validated daily or weekly diaries and any scores from validated visual analogue scales; the total Quality of Life Score (such as the Juniper RQLQ);individual symptoms scores which include any appropriate measures of nasal obstruction, runny nose, sneezing, itching, and eye symptoms; and number of days requiring medication. Secondary outcomes selected will include serum immunoglobin E (IgE) levels, individual ocular symptoms, adverse events, and the use of rescue medication. Treatment effects will be measured by calculating the mean difference and the standardized mean difference with 95% confidence interval (CI) for continuous data. Risk ratio or, if feasible, odds ratio will be calculated with 95% CI for dichotomous data. After assessing clinical and statistical heterogeneity, meta-analysis will be performed, if appropriate. The individual participant will be the unit of analysis. Descriptive information on missing data will be included about participants missing due to drop out, whether there was intention to treat or per protocol analysis and missing statistics. A number of subgroups, homeopathic potency, age groups, and types of allergic rhinitis (seasonal or perennial) will be analyzed. Sensitivity analysis will be performed to explore the impact of risk of bias on overall treatment effect. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42013006741
format Online
Article
Text
id pubmed-4057901
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40579012014-06-15 Homeopathy for allergic rhinitis: protocol for a systematic review Banerjee, Kushal Costelloe, Ceire Mathie, Robert T Howick, Jeremy Syst Rev Protocol BACKGROUND: Allergic rhinitis is a global health problem that is often treated with homeopathy. The objective of this review will be to evaluate the effectiveness of homeopathic treatment of allergic rhinitis. METHODS/DESIGN: The authors will conduct a systematic review. We will search Medline, CENTRAL, CINAHL, EMBASE, AMED, CAM-Quest, Google Scholar and reference lists of identified studies up to December 2013. The review will include randomized controlled trials that evaluate homeopathic treatment of allergic rhinitis. Studies with participants of all ages, with acute or chronic comorbidities will be included. Patients with immunodeficiency will not be included. The diagnosis will be based on the published guidelines of diagnosis and classification. Studies of all homeopathy modalities (clinical, complex and classical homeopathy, and isopathy) will be included. We will include trials with both active controls (conventional therapy, standard care) and placebo controls. The primary outcomes are: an improvement of global symptoms recorded in validated daily or weekly diaries and any scores from validated visual analogue scales; the total Quality of Life Score (such as the Juniper RQLQ);individual symptoms scores which include any appropriate measures of nasal obstruction, runny nose, sneezing, itching, and eye symptoms; and number of days requiring medication. Secondary outcomes selected will include serum immunoglobin E (IgE) levels, individual ocular symptoms, adverse events, and the use of rescue medication. Treatment effects will be measured by calculating the mean difference and the standardized mean difference with 95% confidence interval (CI) for continuous data. Risk ratio or, if feasible, odds ratio will be calculated with 95% CI for dichotomous data. After assessing clinical and statistical heterogeneity, meta-analysis will be performed, if appropriate. The individual participant will be the unit of analysis. Descriptive information on missing data will be included about participants missing due to drop out, whether there was intention to treat or per protocol analysis and missing statistics. A number of subgroups, homeopathic potency, age groups, and types of allergic rhinitis (seasonal or perennial) will be analyzed. Sensitivity analysis will be performed to explore the impact of risk of bias on overall treatment effect. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42013006741 BioMed Central 2014-06-10 /pmc/articles/PMC4057901/ /pubmed/24913155 http://dx.doi.org/10.1186/2046-4053-3-59 Text en Copyright © 2014 Banerjee et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Protocol
Banerjee, Kushal
Costelloe, Ceire
Mathie, Robert T
Howick, Jeremy
Homeopathy for allergic rhinitis: protocol for a systematic review
title Homeopathy for allergic rhinitis: protocol for a systematic review
title_full Homeopathy for allergic rhinitis: protocol for a systematic review
title_fullStr Homeopathy for allergic rhinitis: protocol for a systematic review
title_full_unstemmed Homeopathy for allergic rhinitis: protocol for a systematic review
title_short Homeopathy for allergic rhinitis: protocol for a systematic review
title_sort homeopathy for allergic rhinitis: protocol for a systematic review
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057901/
https://www.ncbi.nlm.nih.gov/pubmed/24913155
http://dx.doi.org/10.1186/2046-4053-3-59
work_keys_str_mv AT banerjeekushal homeopathyforallergicrhinitisprotocolforasystematicreview
AT costelloeceire homeopathyforallergicrhinitisprotocolforasystematicreview
AT mathierobertt homeopathyforallergicrhinitisprotocolforasystematicreview
AT howickjeremy homeopathyforallergicrhinitisprotocolforasystematicreview